Category: HPB & Spleen

Intraoperative Blood Loss Affects Pancreatic Fistula Rates

Intraoperative blood loss is a key risk factor for postoperative pancreatic fistula (POPF) in pancreatic surgery, impacting patient recovery. Among 13,108 patients, the overall POPF rate was 20%. In patients with POPF, intraoperative blood loss was 112.46 ml higher than those without, highlighting its significance as an independent risk factor. Minimizing blood loss during surgery […]

Strategies to Reduce Delayed Gastric Emptying Post-Pancreatic Surgery

Delayed gastric emptying (DGE) is a major complication after pancreatic surgery, impacting recovery and hospital stays. The overall DGE grade B/C rate was 11.9%, with 12.7% after pancreatoduodenectomy and 4.2% after left pancreatectomy. No effective treatments for DGE were found, but 12 strategies showed promise in reducing rates, notably minimally invasive left pancreatectomy. Minimally invasive […]

Neoadjuvant Therapy Improves Outcomes in Intrahepatic Cholangiocarcinoma

Neoadjuvant chemotherapy followed by surgery significantly improves survival and reduces recurrence in patients with potentially resectable intrahepatic cholangiocarcinoma. Median overall survival was 52.9 months for neoadjuvant therapy versus 37.0 months for upfront surgery. Recurrence risk was lower at 57.7% compared to 65.7%, and the time to relapse extended to 16.5 months from 10.7 months. This […]

Predicting Liver Failure After Hepatectomy: Key Early Indicators

Early liver function tests can help surgeons identify patients at risk for post-hepatectomy liver failure (PHLF), improving outcomes. In a study of 445 patients, 8.5% developed PHLF. On postoperative day 3, bilirubin ≥1.8 mg/dl (sensitivity 93.3%) and INR ≥1.18 (sensitivity 80.6%) strongly predicted PHLF. Relying on current guidelines starting at day 5 could delay important […]

Bile Duct Injury Repair Insights: Delayed is Safer

Delayed repair for bile duct injuries (BDIs) following cholecystectomy significantly lowers reoperation and mortality rates. Early repair increases reoperation rates by 3.31 times and stricture rates by 7.41 times compared to late repair. Non-operative management leads to a staggering 16.60 higher reoperation rate than operative interventions. Surgeons should prioritize delayed repair to improve patient outcomes […]

New predictive models identify risks for liver tumor rupture

Understanding the risk factors for hepatocellular carcinoma (HCC) rupture can improve surgical outcomes. Key risk factors include cirrhosis, protrusion ratio, and maximum tumor length. The new capture nomogram achieved AUC values of 0.857, 0.824, and 0.840 across training, validation, and test groups, indicating high predictive accuracy. Using these models can enhance early risk assessment and […]

One-stage surgery beats two-stage for unresectable liver metastases.

Median overall survival was 46.5 months for one-stage versus 34.0 months for two-stage (p = 0.043). Complication rates were similar: 11% for one-stage and 13% for two-stage (p = 0.567). Local treatment was more successful with one-stage surgery, achieving complete resection or ablation in 52 patients compared to 29 in the two-stage group (p < […]

Laparoscopic Liver Resection in Segment 7 Shows Promise

Laparoscopic liver resection (LLR) for malignancies in segment 7 is a viable option, with potential short-term benefits. LLR led to shorter hospital stays and a trend toward reduced blood loss compared to open liver resection (OLR). Over 30 cases, the conversion rate to OLR decreased, indicating improved surgical safety with experience. Surgeons can consider LLR […]

New Prognostic Tool for Acute Pancreatitis Outcomes

A novel Neutrophil-C-Reactive Protein Index (NCI) can enhance risk stratification for severe acute pancreatitis and in-hospital mortality, crucial in resource-limited settings. Optimal NCI cut-off values are ≥1877 for severe pancreatitis and ≥3180 for mortality. NCI predictions for severe pancreatitis had AUCs of 0.853 to 0.897 across different patient cohorts, outperforming other biomarkers. This tool leverages […]

Empowering Junior Surgeons in Laparoscopic CBD Exploration

Junior surgeons can safely perform laparoscopic common bile duct exploration with excellent outcomes. 962 patients were studied, yielding an overall success rate of 84.4%. Junior operators had a success rate of 87.3% and a low bile leak rate of 0.5%. Encouraging junior surgeons to take on primary roles can enhance their skills while ensuring patient […]